Literature DB >> 9422438

Differences in older versus younger hemodialysis patients' noncompliance with oral medications.

R B Curtin1, B L Svarstad, D Andress, T Keller, P Sacksteder.   

Abstract

Hemodialysis patients' compliance with their therapeutic regimens, including dietary and fluid restrictions, dialysis treatments and medications, is generally suboptimal. Recently, the mean age of the dialysis population has increased. Since impaired cognitive function, which sometimes accompanies aging, interferes with the ability to comprehend instructions, elderly dialysis patients might be at greater risk for noncompliance than are their younger counterparts. In this project, 135 hemodialysis patients (68 patients > 65 years of age and 67 patients < or = 65 years) were studied. Rates of noncompliance with oral antihypertensives and phosphate binders, as tracked by a medication event monitoring system (MEMS), are reported here. More than 42% of older patients (> 65) and 47% of younger patients (< or = 65) were repeated noncompliers with antihypertensives, missing at least 20% of the prescribed doses. Similarly, 65% of older patients and 80% of younger patients exhibited repeated noncompliance with phosphate binders. Almost 30% of older patients and more than 32% of younger patients missed their antihypertensives completely on 20% or more of the prescribed days. Only 18% of the older subjects, but 33% of younger patients missed taking their phosphate binders for 20 or more percent of the prescribed days. Rates of noncompliance were found to differ between the two populations of patients in that younger patients made significantly more dosing errors with their antihypertensives and missed taking their phosphate binders on more days than did their older counterparts.

Entities:  

Mesh:

Year:  1997        PMID: 9422438     DOI: 10.1023/a:1008267104024

Source DB:  PubMed          Journal:  Geriatr Nephrol Urol        ISSN: 0924-8455


  10 in total

Review 1.  Compliance with prescribed drugs: challenges for the elderly population.

Authors:  S Claesson; A Morrison; A I Wertheimer; M L Berger
Journal:  Pharm World Sci       Date:  1999-12

2.  Hyperphosphatemia in children receiving peritoneal dialysis--an educational program.

Authors:  Richard T Blaszak; Mark M Mitsnefes; Mohammad Ilyas; Scarlett D Salman; Sue M Belcher; Debbie R Brady
Journal:  Pediatr Nephrol       Date:  2005-05-05       Impact factor: 3.714

Review 3.  Medication non-adherence in the elderly: how big is the problem?

Authors:  Carmel M Hughes
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

4.  Psychotropic medication in geriatric psychiatric patients: use and unreported use in relation to serum concentrations.

Authors:  Marit Tveito; Jørgen G Bramness; Knut Engedal; Bernhard Lorentzen; Helge Refsum; Gudrun Høiseth
Journal:  Eur J Clin Pharmacol       Date:  2014-07-18       Impact factor: 2.953

Review 5.  Adherence to medication in patients with dementia: predictors and strategies for improvement.

Authors:  Sönke Arlt; Reinhard Lindner; Alexander Rösler; Wolfgang von Renteln-Kruse
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

6.  The Team Education and Adherence Monitoring (TEAM) trial: pharmacy interventions to improve hypertension control in blacks.

Authors:  Bonnie L Svarstad; Jane Morley Kotchen; Theresa I Shireman; Stephanie Y Crawford; Pamela A Palmer; Eva M Vivian; Roger L Brown
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-05

Review 7.  Adherence to prescribed oral medication in adult patients undergoing chronic hemodialysis: a critical review of the literature.

Authors:  Holger Schmid; B Hartmann; H Schiffl
Journal:  Eur J Med Res       Date:  2009-05-14       Impact factor: 2.175

Review 8.  Nonadherence to Medication Therapy in Haemodialysis Patients: A Systematic Review.

Authors:  Saurav Ghimire; Ronald L Castelino; Nicole M Lioufas; Gregory M Peterson; Syed Tabish R Zaidi
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

Review 9.  Individual factors increasing complexity of drug treatment-a narrative review.

Authors:  Steffen J Schmidt; Viktoria S Wurmbach; Anette Lampert; Simone Bernard; Walter E Haefeli; Hanna M Seidling; Petra A Thürmann
Journal:  Eur J Clin Pharmacol       Date:  2020-04-01       Impact factor: 2.953

Review 10.  Phosphate-control adherence in hemodialysis patients: current perspectives.

Authors:  Ebele M Umeukeje; Amanda S Mixon; Kerri L Cavanaugh
Journal:  Patient Prefer Adherence       Date:  2018-07-04       Impact factor: 2.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.